Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 31;8(4):71.
doi: 10.3390/metabo8040071.

Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease

Affiliations

Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease

Stewart F Graham et al. Metabolites. .

Abstract

For people with Parkinson's disease (PD), considered the most common neurodegenerative disease behind Alzheimer's disease, accurate diagnosis is dependent on many factors; however, misdiagnosis is extremely common in the prodromal phases of the disease, when treatment is thought to be most effective. Currently, there are no robust biomarkers that aid in the early diagnosis of PD. Following previously reported work by our group, we accurately measured the concentrations of 18 bile acids in the serum of a prodromal mouse model of PD. We identified three bile acids at significantly different concentrations (p < 0.05) when mice representing a prodromal PD model were compared with controls. These include ω-murichoclic acid (MCAo), tauroursodeoxycholic acid (TUDCA) and ursodeoxycholic acid (UDCA). All were down-regulated in prodromal PD mice with TUDCA and UDCA at significantly lower levels (17-fold and 14-fold decrease, respectively). Using the concentration of three bile acids combined with logistic regression, we can discriminate between prodromal PD mice from control mice with high accuracy (AUC (95% CI) = 0.906 (0.777⁻1.000)) following cross validation. Our study highlights the need to investigate bile acids as potential biomarkers that predict PD and possibly reflect the progression of manifest PD.

Keywords: bile acids; biomarkers; mass spectrometry; prodromal Parkinson’s disease; α-synuclein aggregates.

PubMed Disclaimer

Conflict of interest statement

P.B. has received commercial support as a consultant from Renovo Neural, Inc., Fujifilm-Cellular Dynamics, Axial Biotherapeutics, Roche, Teva Inc., Lundbeck A/S, NeuroDerm, AbbVie, ClearView Healthcare, FCB Health, IOS Press Partners and Capital Technologies, Inc. He is conducting sponsored research on behalf of Roche and Lundbeck A/S. He has ownership interests in Acousort AB, Lund, Sweden. The other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The mean distribution (±SEM) for each of the three significantly different bile acids between mice injected with HuMonomers and PFFs.
Figure 2
Figure 2
The ROC plot for the logistic regression diagnostic algorithm.
Figure 3
Figure 3
Depiction of Bile Acid Metabolism in the liver and gut of mice. Bile acids outlined in blue are neuroprotective, bile acids outlined in red are cytotoxic and those bile acids in red with an accompanying asterisk are statistically significantly different between HuMonomer- and PFF-injected mice. The section detailing Muricholic acid (MCA) only occurs in mice.

References

    1. De Lau L.M., Breteler M.M. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–535. doi: 10.1016/S1474-4422(06)70471-9. - DOI - PubMed
    1. Kalia L.V., Lang A.E. Parkinson’s disease. Lancet. 2015;386:896–912. doi: 10.1016/S0140-6736(14)61393-3. - DOI - PubMed
    1. Tysnes O.-B., Storstein A. Epidemiology of Parkinson’s disease. J. Neural Transm. 2017;124:901–905. doi: 10.1007/s00702-017-1686-y. - DOI - PubMed
    1. Schapira A.H.V., Chaudhuri K.R., Jenner P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 2017;18:435–450. doi: 10.1038/nrn.2017.62. - DOI - PubMed
    1. Postuma R.B., Berg D. Advances in markers of prodromal Parkinson disease. Nat. Rev. Neurol. 2016;12:622–634. doi: 10.1038/nrneurol.2016.152. - DOI - PubMed

LinkOut - more resources